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Purpose. To report a case with transient anisocoria after corneal collagen cross-linking (CXL). Methods. Case report. Results. A
24-year-old male underwent corneal collagen cross-linking (CXL) in his right eye for keratoconus. At the end of the procedure, the
pupil of the treated eye was irregular and dilated, while the pupil of the fellow eye was round, regular, and reactive (anisocoria).
The following day, pupils were round, regular, and reactive in both eyes. Conclusion. Anisocoria may be a transient and innocuous
complication after CXL. A possible cause for this complication might be the anesthetic drops used before and during the surgical
procedure or/and the ultraviolet A irradiation during the treatment.
1. Introduction
Corneal collagen cross-linking (CXL) is a minimally invasive
surgical procedure used for the management of corneal
ectatic disorders such as keratoconus and post-LASIK
corneal ectasia [1, 2]. Riboflavin in conjunction with ultra-
violet A (UVA) irradiation strengthens the corneal tissue
and increases biomechanical stability of the ectatic cornea
[1]. Several studies have reported stabilization and arresting
keratoconus progression afterCXL treatment [1–6].However,
several complications after CXL have already been reported
[7–14]. In this case, we present a patient with dilated and
irregular pupil of the CXL-treated eye at the end of the
procedure.
2. Case Report
A twenty-four-year-old male with progressive keratoconus
presented to our institute for evaluation. At the time of
examination, uncorrected distance visual acuity (UDVA)
was 20/100 in the right eye and 20/200 in the left eye.
Corrected distance visual acuity (CDVA)was 20/25 (manifest
refraction +0.25–3.50 × 70) and 20/40 (manifest refraction
+1.50–6.50 × 110) in the right and left eyes, respectively.
Keratometric readings were 47.79/44.29 diopters (D) and
52.81/46.56D in the right and left eyes, respectively. Central
corneal thickness (CCT) was 451𝜇m and 429 𝜇m for the
right and left eyes, respectively. Ocular and medical histories
were unremarkable. Slit-lamp examination showed no other
anterior or posterior abnormality. The patient was advised
to undergo CXL treatment in both eyes starting with the
right eye. The patient underwent CXL treatment in his right
eye.
After topical anesthesia with proparacaine hydrochloride
0.5% eye drops (Alcaine; Alcon Laboratories, Inc., Fort
Worth, Texas, USA), CXL was conducted according to the
Dresden protocol [1]. At the end of the procedure, the pupil
was irregular and dilated but reactive to light; the pupil of
the fellow eye was round, regular, and reactive (anisocoria)
(Figure 1). A bandage contact lens (BCL) was applied until
full reepithelialization. Intraocular pressure estimated with
digital palpation through closed eyelidswas normal and equal
compared to the contralateral eye. Postoperative medication
included ofloxacin (Exocin, Allergan Pharmaceuticals Ltd.)
four times daily and chloramphenicol/dexamethasone drops
(Dispersadron, Thea Laboratories, Inc.) four times daily
until the epithelium healed completely. The patient was
encouraged to use artificial tears at least six times per day.
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Figure 1: Patient’s photo showing irregular and dilated pupil of the
treated right eye at the end of the CXL procedure (anisocoria).
Figure 2: Patient’s photo with round and regular pupil of both eyes
one day after CXL treatment of the right eye.
On the first postoperative day, slit-lamp examination of
the treated eye revealed a regular, round, and reactive pupil
(Figure 2); cornea showed slight edema and epithelial defect.
On the fourth postoperative day, corneal epithelium was
completely healed and the contact lens was removed.
3. Discussion
CXL is generally considered a safe and efficient surgical
intervention for the treatment of corneal ectatic disorders,
such as keratoconus and post-LASIK ectasia [1–6]. Never-
theless, complications may occur after CXL and have already
been reported [7–14]. Although some of them are mild and
innocuous, others could be severe and result in permanent
decrease of visual acuity.
In this case report, we describe a patient with irregular
and dilated pupil of the treated eye immediately after CXL
procedure; the pupil of the fellow eye was round, regular, and
reactive (anisocoria). The patient had no history of any iris
or pupil size, shape, or reaction anomaly. Although this com-
plication was mild, transient, and innocuous, it raises ques-
tions regarding its cause. One of the possible explanations
may be the effect of proparacaine hydrochloride ophthalmic
solution, which was used for anesthesia before and during
the procedure; one of the proparacaine hydrochloride eye
drops’ side effects may be pupillary dilation or cycloplegia.
Ultraviolet A irradiation during the treatment might be
another possible cause for this complication, even though
the possible mechanism of the ultraviolet A irradiation effect
on the pupil size remains unclear. Whatever the cause, the
post-CXL anisocoria was innocuous. Even though there is no
evident cause for this transient and innocuous complication
after CXL, we believe that it is important to report and
differentiate it from any preexisting pupillary disorder.
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